Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine.
Oncolytic reovirus is a potential therapeutic for colorectal cancer patients with a mutant KRAS gene. Reovirus hijacks the autophagic machinery and preferentially induces apoptosis in patients with a KRAS mutation. However, reovirus on its own is not currently a viable treatment and requires enhance...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0326029 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849329677458472960 |
|---|---|
| author | Aaron Shaykevich Danbee Chae Isaac Silverman Sanjay Goel Radhashree Maitra |
| author_facet | Aaron Shaykevich Danbee Chae Isaac Silverman Sanjay Goel Radhashree Maitra |
| author_sort | Aaron Shaykevich |
| collection | DOAJ |
| description | Oncolytic reovirus is a potential therapeutic for colorectal cancer patients with a mutant KRAS gene. Reovirus hijacks the autophagic machinery and preferentially induces apoptosis in patients with a KRAS mutation. However, reovirus on its own is not currently a viable treatment and requires enhancement with combination therapies. Carbamazepine, an FDA-approved drug in use for epilepsy, is an autophagy inducer and is used in this study in conjunction with reovirus. The dual treatment was able to reduce cancer viability in mutated KRAS cell lines and was more effective than with reovirus alone. Carbamazepine and reovirus increased autophagy-related proteins and mRNA in mutant KRAS compared to wildtype KRAS which is crucial for autophagy-induced apoptosis. Transmission electron microscopy results show increased autophagosome formation in the combination therapy, as well as a decrease in condensed chromatin. The combination therapy effectively increased the apoptosis induced by reovirus alone and is a viable treatment for patients with a mutant KRAS. |
| format | Article |
| id | doaj-art-237645f99ee047d19225defc4ec77d1c |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-237645f99ee047d19225defc4ec77d1c2025-08-20T03:47:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01206e032602910.1371/journal.pone.0326029Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine.Aaron ShaykevichDanbee ChaeIsaac SilvermanSanjay GoelRadhashree MaitraOncolytic reovirus is a potential therapeutic for colorectal cancer patients with a mutant KRAS gene. Reovirus hijacks the autophagic machinery and preferentially induces apoptosis in patients with a KRAS mutation. However, reovirus on its own is not currently a viable treatment and requires enhancement with combination therapies. Carbamazepine, an FDA-approved drug in use for epilepsy, is an autophagy inducer and is used in this study in conjunction with reovirus. The dual treatment was able to reduce cancer viability in mutated KRAS cell lines and was more effective than with reovirus alone. Carbamazepine and reovirus increased autophagy-related proteins and mRNA in mutant KRAS compared to wildtype KRAS which is crucial for autophagy-induced apoptosis. Transmission electron microscopy results show increased autophagosome formation in the combination therapy, as well as a decrease in condensed chromatin. The combination therapy effectively increased the apoptosis induced by reovirus alone and is a viable treatment for patients with a mutant KRAS.https://doi.org/10.1371/journal.pone.0326029 |
| spellingShingle | Aaron Shaykevich Danbee Chae Isaac Silverman Sanjay Goel Radhashree Maitra Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine. PLoS ONE |
| title | Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine. |
| title_full | Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine. |
| title_fullStr | Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine. |
| title_full_unstemmed | Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine. |
| title_short | Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine. |
| title_sort | modulating autophagy in kras mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine |
| url | https://doi.org/10.1371/journal.pone.0326029 |
| work_keys_str_mv | AT aaronshaykevich modulatingautophagyinkrasmutantcolorectalcancerusingcombinationofoncolyticreovirusandcarbamazepine AT danbeechae modulatingautophagyinkrasmutantcolorectalcancerusingcombinationofoncolyticreovirusandcarbamazepine AT isaacsilverman modulatingautophagyinkrasmutantcolorectalcancerusingcombinationofoncolyticreovirusandcarbamazepine AT sanjaygoel modulatingautophagyinkrasmutantcolorectalcancerusingcombinationofoncolyticreovirusandcarbamazepine AT radhashreemaitra modulatingautophagyinkrasmutantcolorectalcancerusingcombinationofoncolyticreovirusandcarbamazepine |